A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine

Clinical Neurology and Neurosurgery

Volumn 110, Issue 10, 2008, Pages 979-984

  Keskinbora, Kader ^a   Aydinli, Isik ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Amitriptyline; Combination treatment; Migraine prophylaxis; Topiramate

Indexed keywords

AMITRIPTYLINE; TOPIRAMATE;

ADULT; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERSOMNIA; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MONOTHERAPY; PARESTHESIA; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; AMITRIPTYLINE; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CONSTIPATION; DISORDERS OF EXCESSIVE SOMNOLENCE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 54049132838     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.05.025     Document Type: Article

References (26)

1. Goadsby P.J., Lipton R.B., and Ferrari M.D. Migraine-current understanding and treatment. N Engl J Med 346 (2002) 257-270
2. Silberstein S.D., and Freitag F.G. Preventive treatment of migraine. Neurology 60 Suppl. 2 (2003) 38-44
3. Silberstein S.D. Practice parameter: evidence-based guidelines for migraine headache (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 754-762
4. Ashkenazi A., and Silberstein S.D. The evolving management of migraine. Curr Opin Neurol 16 (2003) 341-345
5. Ramadan N.M. Prophylactic migraine therapy: mechanisms and evidence. Curr Pain Headache Rep 8 (2004) 91-95
6. Bigal M.E., Krymchantowski A.V., and Rapoport A.M. Prophylactic migraine therapy: emerging treatment options. Curr Pain Headache Rep 8 (2004) 178-184
7. Campo-Arias A. Antidepressants in migraine prophylaxis: an approximation. Rev Neurol 38 (2004) 864-868
8. Calabresi P., Galletti F., Rossi C., Sarchielli P., and Cupini L.M. Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms. Trends Pharmacol Sci 28 (2007) 188-195
9. Brandes J.L., Saper J.R., Diamond M., Couch J.R., Lewis D.W., Schmitt J., et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 291 (2004) 965-973
10. Silberstein S.D., Neto W., Schmitt J., and Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 61 (2004) 490-495
11. Backonja M.M., Irving G., and Argoff C. Rational multidrug therapy in the treatment of neuropathic pain. Curr Pain Headache Rep 10 (2006) 34-38
12. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 8 Suppl. 7 (1988) 1-96
13. Beck A.T., Steer R.A., Ball R., and Ranieri W.F. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 67 (1996) 588-597
14. Ramadan N.M. Current trends in migraine prophylaxis. Headache 47 (2007) 52-57
15. Kaniecki R, Lucas S. Treatment of primary headache: preventive treatment of migraine. Standards of care for headache diagnosis and treatment. Available at http://www.guideline.gov/summary. Accessed 2004.
16. Gomersall J.D., and Stuart A. Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatry 36 (1973) 684-690
17. Couch J.R., Zeigler D.K., and Hassanein R. Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects. Neurology 26 (1976) 121-127
18. Punay N.C., and Couch J.R. Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 7 (2003) 51-54
19. StoreyJR, Calder C.S., Hart D.E., and Potter D.L. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 41 (2001) 968-975
20. Rapoport A., Mauskop A., Diener H.C., Schwalen S., and Pfeil J. Long-term migraine prevention with topiramate: open-label extension of pivotal trials. Headache 46 (2006) 1151-1160
21. Diener H.C., Bussone G., Van Oene J.C., Lahaye M., Schwalen S., Goadsby P.J., and TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27 (2007) 814-823
22. Silberstein S.D., Lipton R.B., Dodick D.W., Freitag F.G., Ramadan N., Mathew N., et al., Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 47 (2007) 170-180
23. Hamelsky S.W., and Lipton R.B. Psychiatric comorbidity of migraine. Headache 46 (2006) 1327-1333
24. Rampello L., Alvano A., Chiechio S., Malaguarnera M., Raffaele R., Vecchio I., et al. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology 50 4 (2004) 322-328
25. Krymchantowski A.V., Silva M.T., Barbosa J.S., and Alves L.A. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache 42 (2002) 510-514
26. Bulut S., Berilgen M.S., Baran A., Tekatas A., Atmaca M., and Mungen B. Venlafaxine versus amitriptyline in the prophactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg 107 (2004) 44-48